<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Pharma Social Media is Ad Hoc at Expense of Strategy</title>
	<atom:link href="http://prforpharma.com/2010/02/02/pharma-social-media-is-ad-hoc-at-expense-of-strategy/feed/" rel="self" type="application/rss+xml" />
	<link>http://prforpharma.com/2010/02/02/pharma-social-media-is-ad-hoc-at-expense-of-strategy/#utm_source=feed&amp;utm_medium=feed&amp;utm_campaign=feed</link>
	<description>Discussions about social media, PR and marketing for pharmaceutical companies</description>
	<lastBuildDate>Sun, 11 Jul 2010 13:09:56 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
	<item>
		<title>By: Course Correcting the sanofi-aventis Social Media Firestorm &#124; PRforPharma</title>
		<link>http://prforpharma.com/2010/02/02/pharma-social-media-is-ad-hoc-at-expense-of-strategy/comment-page-1/#comment-554</link>
		<dc:creator>Course Correcting the sanofi-aventis Social Media Firestorm &#124; PRforPharma</dc:creator>
		<pubDate>Fri, 12 Mar 2010 14:59:34 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=131#comment-554</guid>
		<description>[...] difficult and there are risks.  That’s why as agencies we need to stop overpromising, neglecting strategy and following the shiny object.  There are risks associated with social media and no program will [...]</description>
		<content:encoded><![CDATA[<p>[...] difficult and there are risks.  That’s why as agencies we need to stop overpromising, neglecting strategy and following the shiny object.  There are risks associated with social media and no program will [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: maverickny</title>
		<link>http://prforpharma.com/2010/02/02/pharma-social-media-is-ad-hoc-at-expense-of-strategy/comment-page-1/#comment-542</link>
		<dc:creator>maverickny</dc:creator>
		<pubDate>Fri, 05 Feb 2010 04:15:38 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=131#comment-542</guid>
		<description>Good points here, Chris.&lt;br&gt;&lt;br&gt;The challenge I see with social media in Pharma is that too many marketers and PR folks see it as a yet another distribution channel for piping messages, rather than building trust and respect through engagement.&lt;br&gt;&lt;br&gt;You might as well hand them a loud hailer and a soapbox and ask them to stand on Hyde Park corner preaching to the masses.&lt;br&gt;&lt;br&gt;The other challenge is that for many, tactics are much easier than strategy; you roll them out, measure before and after and see the relativeness effectiveness fairly quickly.  It&#039;s like adding yet more urgent to do&#039;s on your list without prioritising them by importance though.  Strategy is nerve wracking to many marketers - if you get it wrong, it&#039;s a big public wrong and they worry about their jobs etc.</description>
		<content:encoded><![CDATA[<p>Good points here, Chris.</p>
<p>The challenge I see with social media in Pharma is that too many marketers and PR folks see it as a yet another distribution channel for piping messages, rather than building trust and respect through engagement.</p>
<p>You might as well hand them a loud hailer and a soapbox and ask them to stand on Hyde Park corner preaching to the masses.</p>
<p>The other challenge is that for many, tactics are much easier than strategy; you roll them out, measure before and after and see the relativeness effectiveness fairly quickly.  It&#39;s like adding yet more urgent to do&#39;s on your list without prioritising them by importance though.  Strategy is nerve wracking to many marketers &#8211; if you get it wrong, it&#39;s a big public wrong and they worry about their jobs etc.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: uberVU - social comments</title>
		<link>http://prforpharma.com/2010/02/02/pharma-social-media-is-ad-hoc-at-expense-of-strategy/comment-page-1/#comment-541</link>
		<dc:creator>uberVU - social comments</dc:creator>
		<pubDate>Wed, 03 Feb 2010 19:49:36 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=131#comment-541</guid>
		<description>&lt;strong&gt;Social comments and analytics for this post...&lt;/strong&gt;

This post was mentioned on Twitter by PRforPharma: Can pharma social media take a page out of the business playbook circa 1980?: http://bit.ly/ckn20w #SocPharm...</description>
		<content:encoded><![CDATA[<p><strong>Social comments and analytics for this post&#8230;</strong></p>
<p>This post was mentioned on Twitter by PRforPharma: Can pharma social media take a page out of the business playbook circa 1980?: <a href="http://bit.ly/ckn20w" rel="nofollow">http://bit.ly/ckn20w</a> #SocPharm&#8230;</p>
]]></content:encoded>
	</item>
</channel>
</rss>
